Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannaRoyalty Corp C.CRZ

Healthcare Drug Manufacturers - Major Cannabis
Origin House is a growing cannabis product and brands company operating across key markets in the U.S. and Canada. The company delivers over 130 branded cannabis products to the licensed dispensaries. It provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company operates through two operating segments, The Corporate segment derives income from non-operating investment and The California Operations segment engaged in cultivation, manufacturing, an


CSE:CRZ - Post by User

CannaRoyalty Corp > financial report
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by BiggLebowskion May 30, 2018 3:35pm
115 Views
Post# 28101023

RE:RE:RE:RE:RE:RE:financial report

RE:RE:RE:RE:RE:RE:financial report50 million is actually low end for the numbers we can expect. During the earnings conference call Mark Lustig mentions that the companies internal goal is to have 100 million cdn run rate exiting 2018. Its not far fetched at all when you add up the revenue of all the acquisitions and factor in some growth.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities